Market Access HES data: The UK’s powerful source of real-world evidence HES data not only supports the effective management of health and care services, but it can also power clinical research and innovation.
News ESC: Real-world study gives Wegovy edge over Lilly rival Novo Nordisk has latched onto a real-world study that found its weight-loss drug Wegovy works better than Eli Lilly's fast-growing rival Zepbound.
News Leaked MAHA draft signposts US health reform under Trump A leaked version of the Make America Healthy Again programme for the Trump administration has plenty for the pharma industry to stew over.
R&D From data to impact: How real-world evidence will transform ... Real-world evidence (RWE) has moved from the periphery to the centre of how healthcare decisions are made.
Market Access One in five expressions of interest in UK regulator's pilot ... The MHRA, will be running five pilot dialogues as part of its first year exploring a real-world evidence scientific dialogue programme.
Patients Real-world evidence in CNS research: Past, present, future Large-scale, multi-country real-world evidence (RWE) studies—including in Central Nervous System (CNS) indications—have the potential to deliver critical new insights.
News OpenBind unveils its first AI model for drug discovery A research consortium that aims to make the UK a leader in AI-driven drug discovery, OpenBind, has hit its first major milestone.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.